Which assessment finding should be prioritized for a patient receiving corticosteroids?

Monitoring blood glucose levels is crucial for a patient receiving corticosteroids due to the potential for hyperglycemia, a common side effect of these medications. Corticosteroids, such as prednisone, can induce insulin resistance and increase hepatic gluconeogenesis, leading to elevated blood sugar levels that can be detrimental, especially in patients with pre-existing diabetes or those at risk.

Prioritizing blood glucose assessments allows for timely intervention if levels rise significantly, which could require adjustments in medication or dietary modifications. Moreover, uncontrolled hyperglycemia can lead to severe complications such as diabetic ketoacidosis or hyperglycemic hyperosmolar state, making this assessment critical for patient safety and overall management.

While the other options concerning blood pressure, weight gain, and skin condition are important to monitor as well, they do not pose the same immediate risk for severe complications as hyperglycemia does in the context of corticosteroid therapy. Thus, blood glucose levels take precedence in assessment priorities.